Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4779802
Max Phase: Preclinical
Molecular Formula: C23H16F3N5
Molecular Weight: 419.41
Molecule Type: Unknown
Associated Items:
ID: ALA4779802
Max Phase: Preclinical
Molecular Formula: C23H16F3N5
Molecular Weight: 419.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N#Cc1ccc(CNc2ccc3ncnc(Nc4ccc(C(F)(F)F)cc4)c3c2)cc1
Standard InChI: InChI=1S/C23H16F3N5/c24-23(25,26)17-5-7-18(8-6-17)31-22-20-11-19(9-10-21(20)29-14-30-22)28-13-16-3-1-15(12-27)2-4-16/h1-11,14,28H,13H2,(H,29,30,31)
Standard InChI Key: GACDYSOEDUELDP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 419.41 | Molecular Weight (Monoisotopic): 419.1358 | AlogP: 5.88 | #Rotatable Bonds: 5 |
Polar Surface Area: 73.63 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 4.53 | CX LogP: 5.39 | CX LogD: 5.39 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.42 | Np Likeness Score: -1.61 |
1. Lee JY,Shin YS,Lee J,Kwon S,Jin YH,Jang MS,Kim S,Song JH,Kim HR,Park CM. (2020) Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors., 30 (20.0): [PMID:32781216] [10.1016/j.bmcl.2020.127472] |
Source(1):